Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate‐risk, high‐risk, localized, and locally advanced prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|11|1620-1629

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.11, 2014-06, pp. : 1620-1629

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2713-2719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic outcomes of neoadjuvant and concurrent androgen‐deprivation therapy and intensity‐modulated radiation therapy with gold marker implantation for intermediate‐risk and high‐risk prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 477-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life in patients with high‐risk prostate cancer improves with shorter course of androgen deprivation therapy

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 971-971

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external‐beam radiotherapy with or without androgen deprivation

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3260-3261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3265-3271

John Wiley & Sons Inc

Access to resources Recommend Favorite